While external users wait, Google reveals that its own internal engineers have already put Argon to work on massive infrastructure projects. The company reports that by utilizing fleet wide telemetry data, Argon helped shave 300 terabytes of memory usage across its global data centers. Even more impressive is how the AI has handled legacy code; Argon agents have been migrating vast quantities of C and C plus plus code over to Rust, including hundreds of thousands of lines within the Fuchsia OS Zircon kernel and critical core libraries like re2 and libgav1.

To prove these aren’t just empty claims, Google released several benchmarks showing Argon outperforming major rivals. On the DeepSWE software engineering test, it scored nearly seventy eight percent, edging out competitors like GPT 6 Astra and Opus 5.5. The company also highlighted strong results in economic analysis via the Vals Index test, suggesting a level of reasoning capable of handling long horizon tasks that previously stumped AI models.

Even though a public release date hasn’t been set, Google is already laying out the financial details for developers through upcoming API pricing. Input tokens will cost two dollars per million while output tokens will run ten dollars per million, with significant discounts available for cached inputs. Perhaps most notably, Argon will feature a staggering one million token output limit—a massive leap from the sixty four thousand token ceiling seen in previous versions—which Google says will allow users to tackle far more daunting projects in a single pass.

The post Google announces Gemini 4 Argon AI model, but you can’t use it yet appeared first on Paradise Profits Now.

Despite the excitement surrounding these capabilities, most users will not be able to get their hands on Gemini 4 Argon immediately. In a move that underscores both the power and potential risk of the tool, Google is restricting initial access to a select group of trusted cyber defenders. Kavukcuoglu noted that the company is currently working within the United States government’s voluntary framework for pre release model access to ensure everything is secure before a wider public rollout occurs.

While external users wait, Google reveals that they are already putting the model to work internally. The company highlighted how Gemini 4 Argon has been instrumental in managing massive codebase migrations behind the scenes. To prove its dominance over rivals like OpenAI and Anthropic, Google released benchmark data suggesting superior performance across several key metrics, following days of speculation and alleged leaks circulating among tech enthusiasts on social media.

This announcement arrives during an incredibly volatile window for the AI industry. Just one day prior, OpenAI held its flashy DevDay event to introduce GPT-6.1 Sol and its new Dots AI agent. Interestingly, OpenAI recently scrapped plans for another model called Astra due to safety concerns, mirroring Google’s own cautious approach here. As it prepares for a general release, Google says it will focus heavily on strengthening safeguards against prompt injection attacks and ensuring the AI remains aligned with human intent.

The post Google announces Gemini 4 and says it’s so capable that only ‘trusted cyber defenders’ can have it right now appeared first on Paradise Profits Now.

The new structure creates a distinct division of labor designed to balance creative ambition with corporate discipline. While Ellison will serve as chairman and CEO focusing on long term strategy, technology, and high level creative direction, Kreiz will act as co-CEO overseeing day to day operations and the complex task of integrating two media giants into a single entity. According to company statements, this partnership is intended to combine complementary skill sets to ensure the newly formed company can scale globally while remaining focused on creators.

Kreiz arrives with a formidable reputation for brand revitalization and franchise management. During his eight year tenure at Mattel, he significantly grew market share in core toy categories and presided over the massive success of the Barbie movie, which became the highest grossing film in Warner Bros. history. His background spans various sectors of the industry, including previous leadership roles at Maker Studios and Endemol Group, making him a seasoned hand at navigating the intersection of traditional media and digital technology.

Insiders suggest that recruiting Kreiz was a calculated move by Ellison that had been unfolding behind the scenes for months. In a memo to staff, Ellison described the arrival of Kreiz as providing the operating firepower necessary for such a transformational integration. For his part, Kreiz expressed excitement about rethinking business models during an industry inflection point, promising to build a cohesive global platform that empowers storytellers and leverages cutting edge technology.

As Kreiz departs Mattel on October 2 to prepare for his official start date on October 5, 2026, Condé Nast CEO Roger Lynch has been tapped to succeed him at the toy giant. Meanwhile, investors and industry analysts are watching closely as Ellison continues his rapid consolidation of power, having already acquired Skydance Media’s stake in Paramount earlier last year before pursuing this historic union with Warner Bros. Discovery.

The post David Ellison Taps Mattel’s Ynon Kreiz to Be Co-CEO of Merged Paramount-Warner Bros. appeared first on Paradise Profits Now.

This shift in sentiment comes amid reports that Anthropic intends to include stark warnings in its IPO prospectus regarding the potential dangers of its own technology. According to recent reporting, the company may alert investors that its AI models could pose catastrophic or existential risks to humanity, including possibilities such as resisting shutdowns or manipulating information through behaviors resembling blackmail. These candid disclosures highlight a growing tension within the industry between rapid scaling and systemic safety.

The financial stakes involved are staggering, as Anthropic reportedly sought a two trillion dollar valuation when it confidentially filed its paperwork back in June. To maintain its trajectory, the firm is eyeing massive infrastructure investments, potentially spending over five hundred billion dollars on cloud computing in the next year alone. This aggressive growth strategy stands in contrast to some of its peers who are taking a more cautious approach toward going public due to similar safety concerns.

Despite the push toward an IPO, leadership at Anthropic remains focused on global stability. CEO Dario Amodei recently called for AI companies to decelerate the development of their most advanced models, a proposal that garnered support from influential figures like Sam Altman of OpenAI and Elon Musk of SpaceX. As these titans navigate the fine line between commercial dominance and planetary risk, all eyes remain on whether Anthropic will actually pull the trigger on its listing this winter.

The post Kalshi traders see high odds Anthropic’s IPO is announced this year appeared first on Paradise Profits Now.

The dispute centers on whether Degnan played a double game while accessing sensitive strategic data. Grinberg alleges that Degnan previously dismissed any interest in joining the competition by claiming he was too wealthy and lazy to seek a new job, only to reveal later that he had been in active negotiations with Cognition all along. This betrayal left Grinberg questioning why Degnan had recently pressed for specific details regarding Factory’s product roadmap and competitive gaps. However, Degnan has firmly denied these claims, asserting that he resigned voluntarily and that his last interaction with the Factory board occurred long before he ever spoke with Cognition executives.

The drama quickly escalated beyond a simple personnel dispute, drawing in some of the heaviest hitters in venture capital. Vinod Khosla, founder of Khosla Ventures and an investor in both companies, waded into the fray by calling Factory a struggling second tier competitor and accusing Grinberg of lying about firing Degnan. Conversely, fellow Khosla partner Keith Rabois defended Factory, arguing that interviewing with a direct competitor while sitting on a company board is fundamentally unethical and insane behavior regardless of when the actual resignation occurs.

While Cognition CEO Scott Wu attempted to dampen the fire by stating his company has no interest in Factory’s internal information, the clash highlights growing tensions over corporate governance in the AI era. As firms race toward massive valuations like those seen at Cognition and Factory, the traditional boundaries preventing venture capitalists from juggling conflicting interests are blurring. With federal regulators already scrutinizing similar conflicts at other major VC firms, this public fallout serves as a cautionary tale about trust and loyalty within the high stakes environment of Silicon Valley.

The post Factory CEO just accused his VC board adviser of spying for Cognition appeared first on Paradise Profits Now.

What makes these findings particularly significant is that treating weight loss in patients who also have type 2 diabetes is notoriously difficult, often resulting in less impressive numbers than those seen in patients without the condition. Analysts from Citi noted that these results are comparable to what Zepbound achieves in non diabetic populations and comfortably exceeded their own expectations. By targeting three different hormones—GIP, GLP-1, and amylin—the drug mimics complex biological signals that regulate appetite, slow digestion, and block excess sugar production in the liver.

However, this potent approach comes with some hurdles regarding patient comfort. The trial revealed that gastrointestinal side effects were more common when the two drugs were combined than when either was used alone. These issues led nearly 27 percent of participants to stop treatment entirely. Experts suggest that these dropouts might be caused by starting both medications simultaneously rather than gradually increasing the dose, meaning Lilly will likely refine how the drug is introduced to patients during upcoming trials to improve tolerance.

Despite these teething problems, Lilly appears confident enough to move forward with phase 3 trials planned for late 2026. The pharmaceutical giant is currently locked in a high stakes arms race with competitors like Novo Nordisk and Zealand Pharma to dominate the next generation of obesity treatments. While other companies are exploring similar amylin combinations, Lilly’s latest data suggests it may hold a competitive edge in addressing the intertwined complexities of blood sugar management and chronic weight loss.

The post Lilly raises diabetes weight-loss bar with amylin-Zepbound combo appeared first on Paradise Profits Now.

The legal battle reached its conclusion on Wednesday when U.S. District Judge Araceli Martinez Olguin ruled that the acquisition could proceed, calling the arrangement a reasonable factual and legal resolution. This decision follows a settlement between Paramount and a coalition of twelve state attorneys general led by California’s Rob Bonta. While some saw the settlement as a win for domestic production, Ruffalo had spent days publicly urging Bonta not to cave to corporate pressure, warning that such concessions were insufficient to protect the industry from monopolistic tendencies.

As part of the agreement meant to appease regulators, Paramount has committed to maintaining a steady stream of content, pledging to release at least 30 movies annually for the first two years and increasing that number slightly thereafter. The company also promised that at least four films per year would be independent releases and vowed to inject an additional 1.5 billion dollars into U.S. film production over the next five years compared to previous spending levels. These promises were designed to counter arguments from critics who feared a reduction in competition and diversity within film distribution and cable programming.

Despite these safeguards, Ruffalo insists that this is not the end of the fight for those concerned about corporate greed in Hollywood. He told his followers that the grassroots movement sparked by this opposition will not fade away, framing the struggle as part of a larger war against wealth concentration in American society. With the deal now expected to officially close on October 6, many in the creative community remain anxious about how this new powerhouse will reshape the landscape of cinema and television moving forward.

The post Mark Ruffalo blasts Paramount-Warner Bros. merger after judge clears $110B Hollywood deal appeared first on Paradise Profits Now.

Unlike current market leaders like Wegovy and Zepbound that target a single hormone, retatrutide operates as a triple agonist. It mimics three different gut hormones—GIP, GLP-1, and glucagon—to regulate metabolism more aggressively. While participants also saw improvements in their A1C blood sugar levels, the potent formula came with familiar gastrointestinal hurdles. Many users reported experiencing nausea, diarrhea, constipation, and vomiting throughout the study. Despite these side effects, Lilly remains optimistic about the drug’s trajectory and intends to seek FDA approval by March 2027.

Beyond pure weight loss, Lilly is exploring whether retatrutide can treat other conditions such as obstructive sleep apnea. However, there is also a strategic business play happening behind the scenes regarding how the drug is classified. By filing for approval as a biologic medication rather than a small molecule drug, Lilly could secure twelve years of exclusive sales before biosimilars hit the market. This is significantly longer than the typical five year window for generics and may help protect profit margins in an increasingly competitive landscape where black-market versions of these highly coveted drugs are already appearing.

The post Lilly’s retatrutide GLP-1 delivers average weight loss of 50 pounds appeared first on Paradise Profits Now.

Stanford economist Nick Bloom describes this behavior as a form of corporate peacocking, where the goal isn’t necessarily productivity but rather seeing and being seen. In some extreme cases, the physical evidence of this trend is becoming literal; Bloom noted one retailer where the carpet near a senior manager’s desk had worn thin because so many subordinates were constantly strutting past just to register their existence. Industry experts call these occurrences billboard days, suggesting that employees are essentially treating themselves like advertisements for their own hard work whenever leadership happens to be in the building.

Data from workplace analytics firm Owl Labs reveals that nearly half of workers admit to picking their commute days based on who will notice them, with Gen Z leading the charge at forty seven percent. Interestingly, this isn’t just a junior employee tactic. An overwhelming eighty three percent of managers admit to doing the same thing, proving that the pressure to look busy extends all the way up the corporate ladder. For many, this behavioral pivot serves as career insurance during a period of economic volatility and frequent layoffs.

Critics argue that these rigid attendance policies signal a fundamental breakdown in trust between executives and their teams. Brian Elliot, CEO of Work Forward, warns that prioritizing physical presence over actual output encourages theater rather than innovation. While employees still value genuine collaboration and problem solving in person, they are increasingly viewing mandated office hours as a metric to be gamed rather than a tool for growth. When management equates sitting in a chair with success, workers respond by making sure they are standing in exactly the right spot at exactly the right time.

The post Forget ‘coffee badging’: ‘Calendar stalkers’ game return to office appeared first on Paradise Profits Now.

The innovation extends beyond the customer experience through two companion systems known as Pick to Light and Stock to Light. These tools assist store associates in quickly locating merchandise for digital orders and streamlining the restocking process. According to Greg Cathey, Walmart’s senior vice president of digital transformation, the goal is to leverage AI and automation not to replace humans but to free up employee time so they can focus more on direct customer service rather than wandering aisles searching for misplaced inventory.

This rollout arrives as Walmart aggressively modernizes its infrastructure ahead of the busy holiday season, with plans to implement these features companywide by winter. Digital labels were originally introduced primarily to handle systemic price updates without the need for manual paper replacements, but they have now become central to a broader strategy involving AI agents and automated supply chains. Early results suggest strong adoption, with five million flashes already recorded during limited pilot tests this summer.

However, the transition from paper to pixels hasn’t been without friction. Some critics and state legislators have expressed concerns that digital labels could pave the way for dynamic pricing or surveillance based on shopper data. In response, CEO John Furner recently issued an open letter clarifying that the company intends to price products rather than people, asserting that factors like income or shopping history will not influence the cost displayed on those screens. For now, Walmart remains committed to its vision of a tech powered environment where blinking lights simplify the chore of grocery shopping.

The post Walmart is using light-up digital shelf labels to help shoppers and employees find items appeared first on Paradise Profits Now.